Exalpha Biologicals, Inc.

Accelerating the Pace of Discovery

Product Highlight

Mouse anti-M13 phage coat protein g8p

Antibodies recognising M13 filamentous phage coat proteins are instrumental in the selection and detection of phages expressing specific antibody fragments or peptide sequences at their surface. The monoclonal antibodies manufactured and supplied by Exalpha react with either the pIII (g3p) or pVIII (g8p) proteins of M13 filamentous bacteriophage. All antibodies are available in a purified format. The antibodies are fully validated and are suitable for a wide range of techniques including:

  • Flow Cytometry
  • Western Blot
  • Immunohistochemistry
  • Immunoprecipitation
For more information, click here for our M13 Bacteriophage information page.


Two more of our excellent products have been published by PubMed:

Potential actionable targets in appendiceal cancer detected by immunohistochemistry, fluorescent in situ hybridization, and mutational analysis
Borazanci, E., et al., J. Gastrointest. Oncol., 8, 164-172 (2017)
Using Exalpha SPARC Antibody (Cat. No. X1867P)

Molecular mechanism underlying the pharmacological interactions of the protein kinase C-β inhibitor enzastaurin and erlotinib in non-small cell lung cancer cells
Steen, N.V., et al., Am. J. Cancer Res., 7, 816-830 (2017)
Using Exalpha's FITC labeled anti PY20 Antibody (Cat. No. X1017)

Exalpha Biologicals, Inc.

BrdU Cell Proliferation

  • Product Code: X1327K3
  • Size: 5000 Tests
  • Availability: In Stock In Stock
  • Price (USD): $1844

Cat #

X1327K3		 Quantity:      

Data Sheet

Product Name

BrdU Cell Proliferation

Product Type

Assay Kit


BrdU Incorporated Cells




5000 Tests

Price (USD)


Customer Storage

Store kit at -20°C until first use. Store at 4-8°C thereafter.

Product Specific References

This product has been used in:

1. Chang, V., et al, 'Adenoviral-mediated gene transfer of ectodysplasin-A2 results in induction of apoptosis and cell-cycle arrest in osteosarcoma cell lines.' Cancer Gene Therapy 2007, 14, , 927-933
2. Sekine, C., et al, 'Successful Treatment of Animal Models of Rheumatoid Arthritis with Small-Molecule Cyclin-Dependent Kinase Inhibitors' Journal of Immunology 2008, 180, , 1954-1961
3. Matta, H., et al, 'Activation of alternative NF- B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 -converting enzyme inhibitory protein (vFLIP)' PNAS 2004, 101, , 9399-9404
4. Manov, I., et al. ‘Pronounced cancer resistance in a subterranean rodent, the blind mole-rat, Spalax: in vivo and in vitro evidence.’ BMC Biol., 2013, 11, 91
5. Sharvit, E., et al. ‘Amplified Inhibition of Stellate Cell Activation Pathways by PPAR-γ, RAR and RXR Agonists.’ PLoS One, 2013, 8, e76541
6. Lenarduzzi, M., et al. ‘Hemochromatosis Enhances Tumor Progression via Upregulation of Intracellular Iron in Head and Neck Cancer.’ PLoS One, 2013, 8, e74075
7. Vishwamitra, D., et al. ‘MicroRNA 96 Is a Post-Transcriptional Suppressor of Anaplastic Lymphoma Kinase Expression.’ Am. J. Pathol., 2012, 180, 1772-1780
8. Shirin, H., et al. ‘Atorvastatin and rosuvastatin do not prevent thioacetamide induced liver cirrhosis in rats.’ World J. Gastroenterol., 2013, 19, 241-248
9. Li, L.-D., et al. ‘Effect of active immunization against angiotensin II type 1 (AT1) receptor on hypertension & arterial remodelling in spontaneously hypertensive rats (SHR)’ Indian J. Med. Res. 2014, 139, 619-624
10, Gutschalk, C.M., et al. ‘GM-CSF enhances tumor invasion by elevated MMP-2, -9, and -26 expression’ Cancer Med. 2013, 2, 117-129
11. Boonanantanasam, K., et al. ‘Enterococcus faecalis Enhances Cell Proliferation through Hydrogen Peroxide-Mediated Epidermal Growth Factor Receptor Activation’ Infect. Immun. 2012, 80, 3545-3558